ACAD
ACADIA Pharmaceuticals Inc
20.70$
-6.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.9% | +69.0% | +17.6% | -37.6% | +138.0% | -25.8% | -7.1% | -79.0% | +302.5% | +558.5% | -95.1% | +137.4% | -76.7% | -89.5% | -49.2% | +28,311.5% | +620.7% | +79.2% | +51.5% | +30.3% | +9.6% | +6.8% | +40.4% | +31.8% | +11.9% | |
| – | – | – | +13.1% | +47.9% | +34.2% | +51.6% | +15.4% | -5.5% | -24.3% | -46.6% | -11.0% | +9.1% | +4.0% | +248.6% | -97.3% | +76.2% | +196.4% | +40.4% | +6.9% | +4.9% | -6.9% | -46.9% | +349.8% | +79.0% | +8.7% | |
| – | -13.9% | +69.0% | +17.6% | -37.6% | +138.0% | -25.8% | -7.1% | -79.0% | +302.5% | +558.5% | -95.1% | +137.4% | -621.2% | – | -49.2% | +21,088.5% | +765.3% | +83.7% | +55.5% | +31.8% | +10.4% | +9.0% | +34.2% | +28.7% | +12.2% | |
| – | +34.6% | +14.0% | +13.5% | +38.5% | +31.5% | +60.1% | +17.3% | -2.1% | -26.7% | -50.5% | -15.9% | +8.6% | +42.2% | +126.8% | +21.9% | +34.4% | +50.3% | +25.5% | +28.4% | +32.8% | -25.0% | +51.0% | -2.8% | -13.8% | +8.4% | |
| – | +25.2% | +6.0% | +5.1% | +73.2% | +119.6% | -28.7% | +8.1% | -3.7% | -13.0% | -37.2% | +17.8% | -8.0% | +81.7% | +157.5% | +177.3% | +105.3% | +36.8% | +4.2% | +22.5% | +19.4% | +1.9% | -6.8% | +6.5% | +24.3% | +12.4% | |
| – | +21.9% | -0.5% | +11.7% | +45.4% | +52.3% | +22.3% | +22.8% | -2.3% | -24.4% | -47.9% | -7.8% | +3.5% | +52.9% | +136.7% | +76.4% | +73.5% | +41.5% | +12.0% | +25.0% | +25.0% | -10.2% | +15.0% | +3.2% | -14.4% | +36.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -251.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | -54.6% | |
| – | – | – | – | – | -58.0% | +10.0% | +35.4% | -32.5% | -52.5% | -57.0% | -100.0% | – | – | – | – | – | – | – | – | -42.8% | -26.7% | +5.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -250.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | -46.2% | |
| – | +41.3% | -98.3% | +45.5% | -100.1% | – | – | – | – | – | – | – | – | – | – | – | +306.4% | -16.6% | +12.2% | -30.3% | -30.3% | -42.6% | +621.1% | +305.0% | +208.5% | -897.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -250.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | +72.7% | |
| – | – | – | – | – | – | – | – | – | – | – | -243.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | +50.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.